Protein-Protein Interface Design and Binding Energy Prediction: Biophysical Principles and Computational Approaches

Introduction

Protein-protein interactions (PPIs) govern virtually all biological processes in veterinary systems, including viral entry into host cells, immune receptor signaling, pathogen virulence factor assembly, and cellular signal transduction cascades [1, 2]. The structural characterization and rational manipulation of these interfaces represent a central challenge in computational structural biology [3, 4]. Protein-protein interface design encompasses the computational or experimental engineering of amino acid side chains at a binding interface to alter affinity, specificity, or stability of a protein complex [5, 6]. Binding energy prediction, conversely, involves the quantitative estimation of the Gibbs free energy change (Delta G) upon complex formation, a parameter that dictates the equilibrium dissociation constant (Kd) of the interaction [7, 8].

The veterinary relevance of these methods is substantial. Pathogen-host interface engineering can inform the design of decoy receptors, neutralizing miniproteins, or competitive inhibitors against viruses such as highly pathogenic avian influenza (H5N1) or porcine reproductive and respiratory syndrome virus [9, 10]. Similarly, the rational design of protein-based therapeutics targeting bacterial divisome components, such as Escherichia coli FtsQ, relies on accurate interface mapping and binding energy calculations [11]. This review provides an exhaustive technical examination of the biophysical determinants of protein-protein interfaces, computational algorithms for binding energy prediction, and design strategies for modulating these interactions.

Biophysical Determinants of Protein-Protein Interfaces

Interface Surface Area and Shape Complementarity

Protein-protein interfaces are characterized by buried surface area (BSA), defined as the solvent-accessible surface area (SASA) lost upon complex formation [12]. Typical BSA values for transient heterodimeric complexes range from 1200 to 2000 square angstroms, whereas obligate homodimers often exceed 2500 square angstroms [12]. The shape complementarity index (Sc), calculated from the correlation between atomic contact surfaces, quantifies the geometric fit between two interacting partners [12]. High Sc values (greater than 0.7) indicate tight packing, whereas lower values suggest interfacial plasticity or induced fit upon binding [12].

Hydrogen Bond Networks and Salt Bridges

Hydrogen bonds at protein-protein interfaces contribute both enthalpic stabilization and geometric specificity [3, 13]. A typical interface contains 5 to 15 intermolecular hydrogen bonds, with donor-acceptor distances between 2.5 and 3.5 angstroms [13]. Salt bridges, formed between oppositely charged side chains (e.g., lysine and glutamate), provide electrostatic stabilization that can be highly sensitive to the local dielectric environment [14, 13]. The energetic contribution of a single salt bridge ranges from 1 to 5 kcal/mol depending on solvent exposure and surrounding polar groups [14].

Hydrophobic Hot Spots

Alanine scanning mutagenesis studies have established that a small subset of interface residues, termed hot spots, contribute disproportionately to binding free energy [15, 16]. These hot spots are typically enriched in tryptophan, tyrosine, and arginine residues and are surrounded by energetically less important residues that form a hydrophobic O-ring [15]. The O-ring hypothesis posits that hot spot residues are occluded from bulk solvent by a ring of energetically neutral residues, thereby enhancing the desolvation penalty upon binding [15]. Computational identification of hot spots using mixed-solvent molecular dynamics simulations has enabled the discovery of cryptic allosteric pockets adjacent to primary interfaces [15].

Conformational Flexibility and Induced Fit

Protein interfaces are not rigid bodies; backbone and side chain conformational changes frequently accompany complex formation [17, 13]. The conformational selection model posits that the bound conformation pre-exists in a small population of unbound states, whereas the induced fit model describes structural rearrangement after initial contact [17]. Frustration analysis, which quantifies local energetic conflicts in a protein structure, has been coupled with membrane dynamics simulations to identify regions of conformational strain at receptor interfaces [17].

Computational Methods for Binding Energy Prediction

Physics-Based Scoring Functions

Binding free energy prediction methods fall into several categories. Physics-based scoring functions compute the sum of van der Waals interactions, electrostatic potentials, desolvation penalties, and entropy losses [7, 8]. The molecular mechanics generalized Born surface area (MM-GBSA) approach calculates the binding free energy as the difference between the free energy of the complex and the sum of the free energies of the individual components [13]. This method averages over snapshots from molecular dynamics trajectories and includes terms for internal energy, electrostatic solvation, nonpolar solvation, and conformational entropy [13].

Knowledge-Based Potentials

Knowledge-based or statistical potentials derive energy terms from the observed frequencies of atomic contacts in a database of known protein structures [7, 8]. The potential of mean force (PMF) approach converts pairwise distance distributions into free energy estimates using the inverse Boltzmann relation [8]. The NNDock2 scoring function employs a neural network trained on decoy sets to rank docking models, achieving improved discrimination between near-native and incorrect poses [8].

Machine Learning and Deep Learning Approaches

Recent advances in deep learning have transformed binding energy prediction. Equivariant neural networks, such as the spatial-attention equivariant network SAKE-PP, process three-dimensional atomic coordinates while respecting rotational and translational symmetries [7]. These models learn complex many-body interactions directly from structural data without explicit feature engineering [7]. The Pythia model suite provides a one-stop platform for protein engineering, integrating sequence-based and structure-based predictions for mutational effects on binding [18]. Graph-based neural networks that encode multi-level feature interactions have demonstrated enhanced accuracy in predicting the impact of missense mutations on PPI affinity [16].

Docking and Scoring Pipelines

Protein-protein docking algorithms generate ensembles of putative complex structures, which are subsequently ranked by scoring functions [8, 19]. The RFDiffusion framework leverages denoising diffusion probabilistic models to generate novel protein binders, incorporating auxiliary potentials that guide the generation toward interfaces with desired geometric and chemical properties [19]. The ProSiteHunter unified framework predicts both protein-nucleic acid and protein-protein binding sites from sequence alone, enabling high-throughput annotation of interface residues [20].

Interface Design Strategies

De Novo Protein Design

De novo design of protein binders involves the computational construction of amino acid sequences that fold into a desired structure and bind a target interface with high affinity [6, 21]. The RFDiffusion approach generates backbone coordinates conditioned on target surface features, followed by sequence design using inverse folding algorithms [19]. Miniproteins, typically 30 to 80 residues in length, have been designed as allosteric modulators of receptor function [21]. The design of high-affinity peptide inhibitors targeting the HPV E1-E2 interface exemplifies the integration of computational design with experimental validation [4].

Peptide and Peptidomimetic Design

Linear and macrocyclic peptides represent a versatile modality for PPI modulation [22, 23]. Macrocyclic peptides combine the binding affinity of larger proteins with improved proteolytic stability and cell permeability [23]. Deterministic branch-selective optimization of peptidomimetic scaffolds has been applied to target tumor necrosis factor alpha, revealing design principles for interface inhibition [22]. Cyclic peptides designed using artificial intelligence have enabled controllable modulation of the CD28 immune checkpoint [24].

Small Molecule Inhibitors and Molecular Glues

Small molecules that disrupt PPIs must bind to relatively flat, featureless interfaces with high specificity [2, 25]. DNA-encoded library screening has identified inhibitors of the SLIT2/ROBO1 interface, demonstrating the feasibility of targeting large, shallow protein surfaces [26]. Covalent molecular glues represent an emerging modality that stabilizes otherwise weak PPIs, leading to targeted protein degradation [27]. The design of covalent glues requires precise positioning of electrophilic warheads near nucleophilic side chains at the interface [27].

Structure-Guided Optimization

Iterative cycles of computational design and experimental characterization remain the gold standard for interface engineering [3, 28]. Structure-guided design of proteomimetics targeting the SARS-CoV-2 spike receptor binding domain and human ACE2 interface illustrates the optimization of binding affinity through systematic mutation of contact residues [3]. The design of compounds targeting the UVRAG-BAX interface required detailed analysis of hydrogen bond networks and hydrophobic packing to achieve pro-apoptotic activity [28].

Workflow for Interface Design and Energy Prediction

The following Mermaid diagram illustrates a typical computational workflow for protein-protein interface design and binding energy prediction.

flowchart TD
    A[Target Protein Structure], > B[Interface Identification]
    B, > C[Hot Spot Prediction]
    C, > D[Scaffold Selection]
    D, > E[Computational Design]
    E, > F[Binding Energy Prediction]
    F, > G[Scoring and Ranking]
    G, > H{Experimental Validation}
    H, >|Pass| I[Lead Optimization]
    H, >|Fail| E
    I, > J[Final Candidate]
    
    B, > K[Surface Area Calculation]
    B, > L[Hydrogen Bond Network Analysis]
    C, > M[Alanine Scanning Simulation]
    C, > N[Mixed-Solvent MD]
    E, > O[Inverse Folding]
    E, > P[Diffusion Model Generation]
    F, > Q[MM-GBSA]
    F, > R[Neural Network Scoring]

Visualization of Interface Residues

Three-dimensional structural visualization is essential for identifying design targets at protein-protein interfaces [12, 9]. Interface residues are typically highlighted using a color-coding scheme based on their physicochemical properties or energetic contribution. Hydrophobic hot spots are colored in shades of green, polar residues in blue, and charged residues in red. The SPICE platform enables comparative structural analysis of protein complexes, allowing users to overlay interface maps from multiple homologs or mutants [12]. The Interactys-AI framework provides automated structural mapping of virus-host interfaces, color-coding residues by evolutionary conservation and predicted binding energy contribution [9].

Applications in Veterinary Structural Bioinformatics

Pathogen-Host Interface Targeting

The design of inhibitors targeting viral entry mechanisms is a direct application of PPI engineering in veterinary medicine [9, 29]. Crimean-Congo hemorrhagic fever virus, a tick-borne pathogen affecting livestock, has been targeted through computational discovery of peptides that bind the viral OTU protease domain [29]. The structural mapping of Mycobacterium tuberculosis short linear PDZ-binding motifs at the host-pathogen interface provides a template for designing competitive inhibitors that block bacterial adhesion [30].

Vaccine Antigen Design

Rational design of vaccine antigens often involves stabilizing specific oligomeric states or presenting conserved epitopes in a immunogenic conformation [10]. Deep learning-driven protein binder design has been applied to crop improvement, but the same methodologies are transferable to veterinary vaccine development [10]. Stabilization of trimeric viral glycoproteins through interface engineering can enhance the immunogenicity of subunit vaccines.

Diagnostic Reagent Engineering

Engineered protein binders, such as designed ankyrin repeat proteins or monobodies, can serve as capture reagents in diagnostic assays [18]. The Pythia platform enables rapid optimization of binder affinity and specificity for use in ELISA or lateral flow formats [18]. Accurate binding energy prediction ensures that designed reagents maintain stability under diagnostic assay conditions.

Challenges and Future Directions

Despite significant progress, several challenges persist in protein-protein interface design and binding energy prediction. The accurate treatment of conformational entropy remains computationally demanding [13]. Solvent effects, including the displacement of ordered water molecules at interfaces, are difficult to model with implicit solvation methods [5]. The Void-X generative model addresses atomic packing prediction, which is critical for designing interfaces with optimal steric complementarity [5].

The druggability assessment of PPI interfaces, as demonstrated for E. coli FtsQ, requires integration of multiple computational tools to identify tractable binding pockets [11]. Emerging modalities, including targeted protein degradation and covalent molecular glues, expand the chemical space available for PPI modulation [27, 31]. The continued development of equivariant neural networks and diffusion models promises to improve the accuracy and generalizability of binding energy predictions [7, 19].

References

[1] Singh S, Singh R, Sharma S. Navigating the uncharted: AI-driven advances in protein structure, dynamics, interactions and ligand interactions for understudied families. BioData Min. 2026. URL: https://pubmed.ncbi.nlm.nih.gov/42310771/

[2] El-Tanani M, Rabbani SA, Wali AF et al. Disrupting the Undruggable: Emerging Modalities for Targeting Protein-Protein Interactions in Oncology. Biology (Basel). 2026. URL: https://pubmed.ncbi.nlm.nih.gov/42187721/

[3] Ferková S, Fayolle A, Boisvert O et al. Structure-Guided Design of Proteomimetics Targeting the SARS-CoV-2 S-RBD/hACE2 Interface. J Med Chem. 2026. URL: https://pubmed.ncbi.nlm.nih.gov/42289940/

[4] Fletcher S, Biswas-Fiss EE, Biswas S. De Novo Design and Computational Validation of a High-Affinity Peptide Inhibitor Targeting the HPV E1-E2 Interface. bioRxiv. 2026. URL: https://pubmed.ncbi.nlm.nih.gov/42282523/

[5] Yang J, Yuan J, Chou JJ. Void-X: A generative void-filling model for predicting atomic packing in proteins. Proc Natl Acad Sci U S A. 2026. URL: https://pubmed.ncbi.nlm.nih.gov/42263125/

[6] Prakash VR, Najy Y, Garrett K et al. De Novo Protein Design Enables Targeting of Intractable Oncogenic Protein-Protein Interfaces. Biologics (Basel). 2026. URL: https://pubmed.ncbi.nlm.nih.gov/42222300/

[7] Xu Y, Xia W, Zhang C et al. SAKE-PP: A Spatial-Attention Equivariant Network for Accurate Ranking of Protein-Protein Interaction Models. JACS Au. 2026. URL: https://pubmed.ncbi.nlm.nih.gov/42212070/

[8] Chae MH, So G, Kim UJ. NNDock2: A neural network-based scoring function for ranking protein-protein docking models. J Bioinform Comput Biol. 2026. URL: https://pubmed.ncbi.nlm.nih.gov/42011127/

[9] Poitras C, Harake A, Grandvaux N et al. Interactys-AI: Toward AI-Driven Structural Mapping of Virus-Host Interfaces for Antiviral Repurposing and Pandemic Preparedness. Biomolecules. 2026. URL: https://pubmed.ncbi.nlm.nih.gov/42072662/

[10] Iqbal MS, Bahitwa R, Azam AA et al. Deep learning-driven protein binder design for crop improvement. aBIOTECH. 2026. URL: https://pubmed.ncbi.nlm.nih.gov/41940160/

[11] Frlan R. In Silico Druggability Assessment of Escherichia coli FtsQ Reveals Tractable PPI Interfaces in the Divisome. Antibiotics (Basel). 2026. URL: https://pubmed.ncbi.nlm.nih.gov/42192652/

[12] Ashraf FB, Lonardi S. Comparative structural analysis of protein complexes with SPICE. Nucleic Acids Res. 2026. URL: https://pubmed.ncbi.nlm.nih.gov/42077125/

[13] Zhu X, Chang J, Fang M et al. Comparative binding mechanisms of SND1 with MTDH and small-molecule inhibitors: insights from molecular dynamics simulations and free energy calculations. Phys Chem Chem Phys. 2026. URL: https://pubmed.ncbi.nlm.nih.gov/41954452/

[14] Kamel EM, Khadrawy SM, Ali MAM et al. Disrupting the KRAS-SOS1 protein-protein interaction: mechanistic rationale for pan-KRAS pathway suppression and combination therapy. Front Chem. 2026. URL: https://pubmed.ncbi.nlm.nih.gov/42022579/

[15] Mukhopadhyay S, Chakrabarty S. Mapping Protein-Protein Interaction Hotspots and Unveiling a Cryptic Allosteric Pocket in PLK1 PBD via Mixed-Solvent Molecular Dynamics. Chemphyschem. 2026. URL: https://pubmed.ncbi.nlm.nih.gov/42112870/

[16] Wu S, Xu N, Xin X et al. Enhancing mutation impact prediction in protein-protein interactions through interpretable graph-based multi-level feature interactions. Bioinformatics. 2026. URL: https://pubmed.ncbi.nlm.nih.gov/41902842/

[17] Cao P, Zhang J, Shen Y et al. MechMemDyn: Coupling Frustration Analysis with Membrane Dynamics to Target the TREM2-DAP12 Complex Interface. J Chem Inf Model. 2026. URL: https://pubmed.ncbi.nlm.nih.gov/42007542/

[18] Sun J, Shi K, Li H et al. PythiaStudio: a one-stop protein engineering platform powered by Pythia model suite. Nucleic Acids Res. 2026. URL: https://pubmed.ncbi.nlm.nih.gov/42136527/

[19] Geraseva E, Bokov G, Polovnikov V et al. Leveraging Auxiliary Potentials in RFDiffusion for the Design of NA-Binding Proteins. J Chem Inf Model. 2026. URL: https://pubmed.ncbi.nlm.nih.gov/41931663/

[20] Hou D, Zhen Q, Lv Z et al. ProSiteHunter: A Unified Framework for Sequence-Based Prediction of Protein-Nucleic Acid and Protein-Protein Binding Sites. Adv Sci (Weinh). 2026. URL: https://pubmed.ncbi.nlm.nih.gov/42227990/

[21] Liu X, Sun Y, Xia Y et al. AI-Driven Design of Miniproteins as Potential Allosteric Modulators. Pharmaceuticals (Basel). 2026. URL: https://pubmed.ncbi.nlm.nih.gov/41901326/ *** Disclaimer: This article is for educational and informational purposes only. It is not intended to substitute for professional veterinary advice, diagnosis, treatment, or regulatory guidance. Always consult a licensed veterinarian or qualified specialist regarding animal health, disease diagnosis, and therapeutic decisions.

[22] Chen H, Song L, Dai Y et al. Deterministic, branch-selective optimization of peptidomimetic scaffolds reveals design principles for targeting TNF-alpha. Eur J Med Chem. 2026. URL: https://pubmed.ncbi.nlm.nih.gov/42218838/

[23] Sunny EA, Sadanandan S. Macrocyclic peptides as protein-protein interaction modulators: a review. Org Biomol Chem. 2026. URL: https://pubmed.ncbi.nlm.nih.gov/42017321/

[24] Kuncewicz K, Upadhyay S, Zhu R et al. AI-Designed Cyclic Peptides Enable Controllable Modulation of the CD28 Immune Checkpoint. Adv Sci (Weinh). 2026. URL: https://pubmed.ncbi.nlm.nih.gov/42216689/

[25] Coelho-Silva JL, Parducci NS, Carvalho MFL et al. Targeting "undruggable" cancer proteins: pharmacological challenges and emerging strategies. Transl Cancer Res. 2026. URL: https://pubmed.ncbi.nlm.nih.gov/42180980/

[26] Garcia-Vazquez N, Yuan S, Gabr M. Discovery and Optimization of Small Molecule Inhibitors of the SLIT2/ROBO1 Protein-Protein Interaction Using DNA-Encoded Libraries. bioRxiv. 2026. URL: https://pubmed.ncbi.nlm.nih.gov/42124605/

[27] Al-Karmalawy AA, Attia MI, Yousef TA et al. Covalent Molecular Glues: Mechanisms, Design Principles, and Emerging Therapeutic Opportunities in Targeted Protein Degradation. Arch Pharm (Weinheim). 2026. URL: https://pubmed.ncbi.nlm.nih.gov/42170909/

[28] Kumar S, Singh RB, Dubey VK. Structure-Based Design of UVRAG-BAX Binding Interface-Targeting Compound Induces Apoptosis and ROS in Breast Cancer Cells. Biochemistry. 2026. URL: https://pubmed.ncbi.nlm.nih.gov/42117566/

[29] Hassam M, Rubina, Zheng H et al. Targeting Crimean-Congo hemorrhagic fever virus: computational and MD-driven discovery of Moringa oleifera peptides against the RdRp-embedded OTU protease. Sci Rep. 2026. URL: https://pubmed.ncbi.nlm.nih.gov/42045402/

[30] Sevilla-Reyes E, Rosas-García J, Gutiérrez-González LH et al. Mycobacterium tuberculosis H37Rv Short Linear PDZ-Binding Motif Proteins at the Host-Pathogen Interface. Int J Mol Sci. 2026. URL: https://pubmed.ncbi.nlm.nih.gov/41977340/

[31] Kamel EM, Khadrawy SM, Ali MAM et al. Disrupting E3 ubiquitin ligase protein-protein interactions in cancer: chemical modalities, mechanisms, and therapeutic opportunities. Biochem Pharmacol. 2026. URL: https://pubmed.ncbi.nlm.nih.gov/41951160/

[32] Guyot A, Maillard E, Ferreira-Pinto K et al. Optimized Quantitative Bacterial Two-Hybrid (qB2H) for Protein-Protein Interaction Assessment. Comput Struct Biotechnol J. 2026. URL: https://pubmed.ncbi.nlm.nih.gov/42199375/

[33] Felicetti T, Zago A, Astolfi A et al. Streamlined Synthesis and Structure-Activity Relationship Analysis of 2-Amidothiophene-3-Carboxamides Targeting Influenza Polymerase PA-PB1 Heterodimerization. ChemMedChem. 2026. URL: https://pubmed.ncbi.nlm.nih.gov/42174748/

[34] Li Y, Gimenez D, Warriner SL et al. Discovery of SHANK1-PDZ Peptide-Fragment Inhibitors Using a Dynamic Ligation Screening Strategy. Biochemistry. 2026. URL: https://pubmed.ncbi.nlm.nih.gov/41944827/

[35] Al-Karmalawy AA, Eissa ME, Yousef TA et al. Targeting the Menin-KMT2A Interface: Medicinal Chemistry Rules Governing Reversible, Covalent, and Degrader Inhibitors. Chem Biol Drug Des. 2026. URL: https://pubmed.ncbi.nlm.nih.gov/41934676/